| Trey Anthony Cline, AUD | |
|
University Of Kentucky Department Of, B317 Kentucky Clinic, Lexington, KY 40536-0284 | |
| (859) 218-2176 | |
| Not Available |
| Full Name | Trey Anthony Cline |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 13 Years |
| Location | University Of Kentucky Department Of, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134410442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 0563 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Kentucky | 3072425289 | 573 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Think about the way our bodies are assembled during early development and ask: How do neighboring cells know that they are supposed to become a nerve or a bone cell and how do these tissues find the correct place and alignment? Researchers at the University of Miami (UM) are answering these crucial questions.
Overprescribing of opioids and opioid addiction are serious and growing public health problems in the U.S., and are the focus of a new report by an expert panel, entitled The American Opioid Epidemic: Population Health Implications and Potential Solutions," from the National Stakeholder Panel, Jefferson College of Population Health, which is published in a special supplement to Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The supplement is available open access on the Population Health Managementwebsite
Arizona has secured an additional $800,000 in federal funds to bolster the state's effort to fight West Nile Virus this year, Arizona Department of Health Services Director Susan Gerard announced this week.
› Verified 3 days ago
| Provider Name | University Of Kentucky |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770771974 PECOS PAC ID: 3072425289 Enrollment ID: O20031105000072 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Think about the way our bodies are assembled during early development and ask: How do neighboring cells know that they are supposed to become a nerve or a bone cell and how do these tissues find the correct place and alignment? Researchers at the University of Miami (UM) are answering these crucial questions.
Overprescribing of opioids and opioid addiction are serious and growing public health problems in the U.S., and are the focus of a new report by an expert panel, entitled The American Opioid Epidemic: Population Health Implications and Potential Solutions," from the National Stakeholder Panel, Jefferson College of Population Health, which is published in a special supplement to Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The supplement is available open access on the Population Health Managementwebsite
Arizona has secured an additional $800,000 in federal funds to bolster the state's effort to fight West Nile Virus this year, Arizona Department of Health Services Director Susan Gerard announced this week.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trey Anthony Cline, AUD University Of Kentucky Department Of, B317 Kentucky Clinic, Lexington, KY 40536-0284 Ph: (859) 218-2176 | Trey Anthony Cline, AUD University Of Kentucky Department Of, B317 Kentucky Clinic, Lexington, KY 40536-0284 Ph: (859) 218-2176 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Think about the way our bodies are assembled during early development and ask: How do neighboring cells know that they are supposed to become a nerve or a bone cell and how do these tissues find the correct place and alignment? Researchers at the University of Miami (UM) are answering these crucial questions.
Overprescribing of opioids and opioid addiction are serious and growing public health problems in the U.S., and are the focus of a new report by an expert panel, entitled The American Opioid Epidemic: Population Health Implications and Potential Solutions," from the National Stakeholder Panel, Jefferson College of Population Health, which is published in a special supplement to Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The supplement is available open access on the Population Health Managementwebsite
Arizona has secured an additional $800,000 in federal funds to bolster the state's effort to fight West Nile Virus this year, Arizona Department of Health Services Director Susan Gerard announced this week.
› Verified 3 days ago
Paula King Evans, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2387 Professional Heights Drive, Suite 30, Lexington, KY 40503 Phone: 859-276-4838 | |
University Of Kentucky Communicative Disorders Audiologist Medicare: Not Enrolled in Medicare Practice Location: 740 S Limestone, Suite B303, Lexington, KY 40536 Phone: 859-257-3390 Fax: 859-323-5951 | |
Sydney Rieman Nance, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1720 Nicholasville Rd Ste 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-277-0541 | |
Shantel J. Dever, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Nicholasville Rd, Suite 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-278-3774 | |
Dr. Courtney Lynn Cooper, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Veterans Dr, Lexington, KY 40502 Phone: 859-281-4972 | |
Abby B. Mattingly, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone St, Suite B317, Lexington, KY 40536 Phone: 859-257-3390 Fax: 859-323-5951 |